Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA Study)-Reference-Cited by-同舟云学术

Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA Study)

Published:2007-10 Issue:8 Volume:100 Page:1245-1248
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Betteridge D. John,Gibson J. Martin,Sager Philip T.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

2. Implications of recent clinical trials for the National Cholesterol Education Program Audit Treatment Panel III guidelines;Grundy;Circulation,2004

3. Pleiotropic effects of statins;Farmer;Curr Atheroscler Rep,2000

4. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention;Ridker;Am J Cardiol,2003

5. C-Reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones;Nesto;Diabet Med,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis;Balkan Medical Journal;2023-09-13

2. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis;BMJ;2022-03-24

3. Comparison of atorvastatin and rosuvastatin on preventing contrast-induced-nephropathy in patients undergoing primary percutaneous coronary intervention: A multi-centric randomized triple-blind clinical trial;Signa Vitae;2020

4. Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial;Current Therapeutic Research;2020

5. Preparation of Patients for Elective Percutaneous Coronary Intervention: Management of Risk Factors as an Approach to Increase in Intervention Efficacy;Medical University;2019-09-01